搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Targeted Oncology
11 小时
Lipsky Discusses Second-Generation BTK Inhibitors in Relapsed/Refractory CLL
During a Case-Based Roundtable® event, Andrew H. Lipsky, MD, moderated a discussion on the efficacy and safety of newer BTK ...
Targeted Oncology
15 小时
c-Met as a Biomarker in Gastric/GEJ Cancers
John Strickler, MD, discusses targeting c-Met as a biomarker in gastric and gastroesophageal junction cancers.
Targeted Oncology
1 天
Long-Term Success With Anti–LAG-3/Anti–PD-1 Combo in Metastatic Melanoma
Meredith McKean, MD, MPH, discussed findings from a longer-term follow-up study evaluating fianlimab plus cemiplimab for the ...
Targeted Oncology
1 天
Bringing Bispecific Antibody Therapy to Community Oncology Centers
In an interview with Targeted Oncology, Courtney Van Houzen, PharmD, shared her experience in bringing bispecific antibody ...
Targeted Oncology
5 天
Machine Learning-Based Tool Aims to Enhance Stereotactic Radiosurgery Outcomes
In an interview with Targeted Oncology, Rupesh Kotecha, MD, discussed a machine learning tool designed to predict local ...
Targeted Oncology
2 天
Eric Cheung: Competence and Compassion are Key to Earning Patients' Trust
Eric Cheung, DO, Targeted Oncology’s second 2024 Oncology Icon, discussed his journey in oncology, advances in treatment, and ...
Targeted Oncology
2 天
Supporting Cancer Survivors: The Clinician's Role
Amy Selly, CNP, AOCNP, discusses how physicians can support their patients' survivorship journeys.
Targeted Oncology
2 天
Trial of PT886 and Pembrolizumab Doses First Patient With Gastric/GEJ Cancer
The first patient with advanced gastric and gastroesophageal cancer has been dosed in a trial combining PT886 with ...
Targeted Oncology
2 天
FDA Approves Inavolisib Plus Standard Therapy in PIK3CA-Mutant Breast Cancer
The approval of inavolisib is supported by findings from the phase 3 INAVO120 study evaluating the agent plus palbociclib and ...
Targeted Oncology
2 天
Talazoparib/Enzalutamide Combo Offers Significant Survival Benefits in Prostate Cancer
According to findings from the TALAPRO-2 study, the combination led to significant and meaningful improvements in overall ...
Targeted Oncology
1 天
Advancements In Obesity Treatment and How This May Impact Cancer In The Future
John M. Burke, MD, examines how new obesity treatments, such as GLP-1 agonists, might influence future cancer rates.
Targeted Oncology
1 天
Goals of Therapy and Considerations for Treatment Sequencing in Extensive Stage Small Cell ...
Ticiana Leal, MD, discusses how in cases of extensive stage small cell lung cancer (ES-SCLC) that progress within 6 months of platinum-based chemotherapy, treatment options such as tarlatamab, ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈